Does Dr. TIFFANY ANDRZEJEWSKI have financial conflicts of interest?

Dr. TIFFANY ANDRZEJEWSKI (OD) has received a total of $26,272 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $26,272 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TIFFANY ANDRZEJEWSKI?

According to CMS Open Payments data, Dr. TIFFANY ANDRZEJEWSKI received funding from COOPERVISION ($10,780), BAUSCH & LOMB AMERICAS ($6,226), and BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US ($5,547).

Does Dr. TIFFANY ANDRZEJEWSKI receive research grants or speaking fees?

Dr. TIFFANY ANDRZEJEWSKI has received $26,272 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TIFFANY ANDRZEJEWSKI

ODReal-Time Hydrated

Specialty: Optometrist, Corneal and Contact Management

Practice Location: HIGHLAND PARK, IL 60035

NPI Number: 1174836548

LIFETIME INDUSTRY VALUE

$26,272

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ANDRZEJEWSKI is a verified Optometrist, Corneal and Contact Management practitioner based in HIGHLAND PARK, IL.

Between 2021 and 2025, Dr. ANDRZEJEWSKI had an overall industry promotional and research financial footprint of $26,272 as recorded in the federal CMS Open Payments database.

$26,272 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANDRZEJEWSKI's primary funding source is COOPERVISION, which accounts for $10,780 (representing 41% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

COOPERVISION

Rank 1

$10,780

41%

BAUSCH & LOMB AMERICAS

Rank 2

$6,226

23.7%

BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US

Rank 3

$5,547

21.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.